American Vietnamese Biotech Incorporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was VND 196,107.08 million compared to VND 281,818.06 million a year ago. Net income was VND 13,581.45 million compared to VND 53,931.41 million a year ago.

Basic earnings per share from continuing operations was VND 104 compared to VND 502 a year ago.